APO Research
Talk to an analyst

APO RESEARCH · REPORT

Meropenem Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Meropenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchMeropenem Injection Industry Research Report 2026151 pages · $2,950 USDIndustry Growth & TrendsGlobal Meropenem Injection Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Meropenem Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Meropenem Injection Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Meropenem Injection Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Meropenem Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Meropenem Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Meropenem Injection include Chongqin Shenghuaxi, Zhejiang Hisun Pharmaceutical, Xinya Pharm, CSPC Group, Shenzhen Haibin Pharmaceutical, Sandoz, Mylan, Luoxin Pharmaceutical and United Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Meropenem Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Meropenem Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Meropenem Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Meropenem Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Meropenem Injection Segment by Company

Chongqin Shenghuaxi

Zhejiang Hisun Pharmaceutical

Xinya Pharm

CSPC Group

Shenzhen Haibin Pharmaceutical

Sandoz

Mylan

Luoxin Pharmaceutical

United Laboratories

Pfizer

Hainan Haiyao Co., Ltd.

Fresenius Kabi

PKU HealthCare

Sumitomo Dainippon Pharma

Sagent Pharmaceuticals

Macleods Pharmaceuticals

Johnlee Pharmaceuticals

Bionova Scientific

AuroMedics

Amneal Pharmaceuticals

Meropenem Injection Segment by Type

0.25g/vial

0.5g/vial

1g/vial

Meropenem Injection Segment by Application

Hospital

Clinics

Others

Meropenem Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Meropenem Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Meropenem Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Meropenem Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Meropenem Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Meropenem Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Meropenem Injection Industry Trends Table 2. Meropenem Injection Industry Drivers Table 3. Meropenem Injection Industry Opportunities and Challenges Table 4. Meropenem Injection Industry Restraints Table 5. Global Meropenem Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Meropenem Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Meropenem Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Meropenem Injection Sales Market Share by Manufacturers Table 9. Global Meropenem Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Meropenem Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Meropenem Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Meropenem Injection Manufacturers, Product Type & Application Table 13. Global Meropenem Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Meropenem Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.25g/vial Table 17. Major Manufacturers of 0.5g/vial Table 18. Major Manufacturers of 1g/vial Table 19. Global Meropenem Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Meropenem Injection Sales by Type (2021-2026) & (K Units) Table 21. Global Meropenem Injection Sales by Type (2027-2032) & (K Units) Table 22. Global Meropenem Injection Sales Market Share by Type (2021-2026) Table 23. Global Meropenem Injection Sales Market Share by Type (2027-2032) Table 24. Global Meropenem Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Meropenem Injection Revenue by Type (2021-2026) & (K Units) Table 26. Global Meropenem Injection Revenue by Type (2027-2032) & (K Units) Table 27. Global Meropenem Injection Revenue Market Share by Type (2021-2026) Table 28. Global Meropenem Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Others Table 32. Global Meropenem Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Meropenem Injection Sales by Application (2021-2026) & (K Units) Table 34. Global Meropenem Injection Sales by Application (2027-2032) & (K Units) Table 35. Global Meropenem Injection Sales Market Share by Application (2021-2026) Table 36. Global Meropenem Injection Sales Market Share by Application (2027-2032) Table 37. Global Meropenem Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Meropenem Injection Revenue by Application (2021-2026) & (K Units) Table 39. Global Meropenem Injection Revenue by Application (2027-2032) & (K Units) Table 40. Global Meropenem Injection Revenue Market Share by Application (2021-2026) Table 41. Global Meropenem Injection Revenue Market Share by Application (2027-2032) Table 42. Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Meropenem Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Meropenem Injection Sales Market Share by Region (2021-2026) Table 45. Global Meropenem Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Meropenem Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 49. North America Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 50. Europe Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 52. Europe Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Meropenem Injection Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Meropenem Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Meropenem Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Meropenem Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Meropenem Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Meropenem Injection Revenue Market Share by Region (2021-2026) Table 63. Global Meropenem Injection Revenue Market Share by Region (2027-2032) Table 64. Chongqin Shenghuaxi Company Information Table 65. Chongqin Shenghuaxi Business Overview Table 66. Chongqin Shenghuaxi Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Chongqin Shenghuaxi Meropenem Injection Product Portfolio Table 68. Chongqin Shenghuaxi Recent Development Table 69. Zhejiang Hisun Pharmaceutical Company Information Table 70. Zhejiang Hisun Pharmaceutical Business Overview Table 71. Zhejiang Hisun Pharmaceutical Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio Table 73. Zhejiang Hisun Pharmaceutical Recent Development Table 74. Xinya Pharm Company Information Table 75. Xinya Pharm Business Overview Table 76. Xinya Pharm Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Xinya Pharm Meropenem Injection Product Portfolio Table 78. Xinya Pharm Recent Development Table 79. CSPC Group Company Information Table 80. CSPC Group Business Overview Table 81. CSPC Group Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. CSPC Group Meropenem Injection Product Portfolio Table 83. CSPC Group Recent Development Table 84. Shenzhen Haibin Pharmaceutical Company Information Table 85. Shenzhen Haibin Pharmaceutical Business Overview Table 86. Shenzhen Haibin Pharmaceutical Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio Table 88. Shenzhen Haibin Pharmaceutical Recent Development Table 89. Sandoz Company Information Table 90. Sandoz Business Overview Table 91. Sandoz Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sandoz Meropenem Injection Product Portfolio Table 93. Sandoz Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Mylan Meropenem Injection Product Portfolio Table 98. Mylan Recent Development Table 99. Luoxin Pharmaceutical Company Information Table 100. Luoxin Pharmaceutical Business Overview Table 101. Luoxin Pharmaceutical Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Luoxin Pharmaceutical Meropenem Injection Product Portfolio Table 103. Luoxin Pharmaceutical Recent Development Table 104. United Laboratories Company Information Table 105. United Laboratories Business Overview Table 106. United Laboratories Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. United Laboratories Meropenem Injection Product Portfolio Table 108. United Laboratories Recent Development Table 109. Pfizer Company Information Table 110. Pfizer Business Overview Table 111. Pfizer Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Pfizer Meropenem Injection Product Portfolio Table 113. Pfizer Recent Development Table 114. Hainan Haiyao Co., Ltd. Company Information Table 115. Hainan Haiyao Co., Ltd. Business Overview Table 116. Hainan Haiyao Co., Ltd. Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio Table 118. Hainan Haiyao Co., Ltd. Recent Development Table 119. Fresenius Kabi Company Information Table 120. Fresenius Kabi Business Overview Table 121. Fresenius Kabi Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Fresenius Kabi Meropenem Injection Product Portfolio Table 123. Fresenius Kabi Recent Development Table 124. PKU HealthCare Company Information Table 125. PKU HealthCare Business Overview Table 126. PKU HealthCare Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. PKU HealthCare Meropenem Injection Product Portfolio Table 128. PKU HealthCare Recent Development Table 129. Sumitomo Dainippon Pharma Company Information Table 130. Sumitomo Dainippon Pharma Business Overview Table 131. Sumitomo Dainippon Pharma Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio Table 133. Sumitomo Dainippon Pharma Recent Development Table 134. Sagent Pharmaceuticals Company Information Table 135. Sagent Pharmaceuticals Business Overview Table 136. Sagent Pharmaceuticals Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Sagent Pharmaceuticals Meropenem Injection Product Portfolio Table 138. Sagent Pharmaceuticals Recent Development Table 139. Macleods Pharmaceuticals Company Information Table 140. Macleods Pharmaceuticals Business Overview Table 141. Macleods Pharmaceuticals Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Macleods Pharmaceuticals Meropenem Injection Product Portfolio Table 143. Macleods Pharmaceuticals Recent Development Table 144. Johnlee Pharmaceuticals Company Information Table 145. Johnlee Pharmaceuticals Business Overview Table 146. Johnlee Pharmaceuticals Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Johnlee Pharmaceuticals Meropenem Injection Product Portfolio Table 148. Johnlee Pharmaceuticals Recent Development Table 149. Bionova Scientific Company Information Table 150. Bionova Scientific Business Overview Table 151. Bionova Scientific Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Bionova Scientific Meropenem Injection Product Portfolio Table 153. Bionova Scientific Recent Development Table 154. AuroMedics Company Information Table 155. AuroMedics Business Overview Table 156. AuroMedics Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. AuroMedics Meropenem Injection Product Portfolio Table 158. AuroMedics Recent Development Table 159. Amneal Pharmaceuticals Company Information Table 160. Amneal Pharmaceuticals Business Overview Table 161. Amneal Pharmaceuticals Meropenem Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Amneal Pharmaceuticals Meropenem Injection Product Portfolio Table 163. Amneal Pharmaceuticals Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Meropenem Injection Distributors List Table 167. Meropenem Injection Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Meropenem Injection Product Image Figure 2. Global Meropenem Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Meropenem Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Meropenem Injection Sales (2021-2032) & (K Units) Figure 5. Global Meropenem Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Meropenem Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.25g/vial Image Figure 9. 0.5g/vial Image Figure 10. 1g/vial Image Figure 11. Global Meropenem Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Meropenem Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Meropenem Injection Sales Market Share by Type (2021-2032) Figure 14. Global Meropenem Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Meropenem Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Meropenem Injection Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Others Image Figure 20. Global Meropenem Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Meropenem Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Meropenem Injection Sales Market Share by Application (2021-2032) Figure 23. Global Meropenem Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Meropenem Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Meropenem Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Meropenem Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Meropenem Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Meropenem Injection Sales Market Share by Country (2021-2032) Figure 40. China Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Meropenem Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Meropenem Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Meropenem Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Meropenem Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Meropenem Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Meropenem Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Meropenem Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Meropenem Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Meropenem Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Meropenem Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g/vial
  • 0.5g/vial
  • 1g/vial
Applications
  • Hospital
  • Clinics
  • Others
Companies covered
  • Chongqin Shenghuaxi
  • Zhejiang Hisun Pharmaceutical
  • Xinya Pharm
  • CSPC Group
  • Shenzhen Haibin Pharmaceutical
  • Sandoz
  • Mylan
  • Luoxin Pharmaceutical
  • United Laboratories
  • Pfizer
  • Hainan Haiyao Co., Ltd.
  • Fresenius Kabi
  • PKU HealthCare
  • Sumitomo Dainippon Pharma
  • Sagent Pharmaceuticals
  • Macleods Pharmaceuticals
  • Johnlee Pharmaceuticals
  • Bionova Scientific
  • AuroMedics
  • Amneal Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Meropenem Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Meropenem Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Meropenem Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Meropenem Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Meropenem Injection Market Dynamics
  1. 2.1 Meropenem Injection Industry Trends
  2. 2.2 Meropenem Injection Industry Drivers
  3. 2.3 Meropenem Injection Industry Opportunities and Challenges
  4. 2.4 Meropenem Injection Industry Restraints
3 Meropenem Injection Market by Manufacturers
  1. 3.1 Global Meropenem Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Meropenem Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Meropenem Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Meropenem Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Meropenem Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Meropenem Injection Manufacturers, Product Type & Application
  7. 3.7 Global Meropenem Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Meropenem Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Meropenem Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Meropenem Injection Tier 1, Tier 2, and Tier 3
4 Meropenem Injection Market by Type
  1. 4.1 Meropenem Injection Type Introduction
  2. 4.1.1 0.25g/vial
  3. 4.1.2 0.5g/vial
  4. 4.1.3 1g/vial
  5. 4.2 Global Meropenem Injection Sales by Type
  6. 4.2.1 Global Meropenem Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Meropenem Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Meropenem Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Meropenem Injection Revenue by Type
  10. 4.3.1 Global Meropenem Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Meropenem Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Meropenem Injection Revenue Market Share by Type (2021-2032)
5 Meropenem Injection Market by Application
  1. 5.1 Meropenem Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Meropenem Injection Sales by Application
  6. 5.2.1 Global Meropenem Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Meropenem Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Meropenem Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Meropenem Injection Revenue by Application
  10. 5.3.1 Global Meropenem Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Meropenem Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Meropenem Injection Revenue Market Share by Application (2021-2032)
6 Global Meropenem Injection Sales by Region
  1. 6.1 Global Meropenem Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Meropenem Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Meropenem Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Meropenem Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Meropenem Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Meropenem Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Meropenem Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Meropenem Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Meropenem Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Meropenem Injection Revenue by Region
  1. 7.1 Global Meropenem Injection Revenue by Region
  2. 7.1.1 Global Meropenem Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Meropenem Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Meropenem Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Meropenem Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Meropenem Injection Revenue (2021-2032)
  8. 7.2.2 North America Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Meropenem Injection Revenue (2021-2032)
  11. 7.3.2 Europe Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Meropenem Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Meropenem Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Meropenem Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqin Shenghuaxi
  2. 8.1.1 Chongqin Shenghuaxi Company Information
  3. 8.1.2 Chongqin Shenghuaxi Business Overview
  4. 8.1.3 Chongqin Shenghuaxi Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Chongqin Shenghuaxi Meropenem Injection Product Portfolio
  6. 8.1.5 Chongqin Shenghuaxi Recent Developments
  7. 8.2 Zhejiang Hisun Pharmaceutical
  8. 8.2.1 Zhejiang Hisun Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Hisun Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Hisun Pharmaceutical Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Hisun Pharmaceutical Meropenem Injection Product Portfolio
  12. 8.2.5 Zhejiang Hisun Pharmaceutical Recent Developments
  13. 8.3 Xinya Pharm
  14. 8.3.1 Xinya Pharm Company Information
  15. 8.3.2 Xinya Pharm Business Overview
  16. 8.3.3 Xinya Pharm Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xinya Pharm Meropenem Injection Product Portfolio
  18. 8.3.5 Xinya Pharm Recent Developments
  19. 8.4 CSPC Group
  20. 8.4.1 CSPC Group Company Information
  21. 8.4.2 CSPC Group Business Overview
  22. 8.4.3 CSPC Group Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CSPC Group Meropenem Injection Product Portfolio
  24. 8.4.5 CSPC Group Recent Developments
  25. 8.5 Shenzhen Haibin Pharmaceutical
  26. 8.5.1 Shenzhen Haibin Pharmaceutical Company Information
  27. 8.5.2 Shenzhen Haibin Pharmaceutical Business Overview
  28. 8.5.3 Shenzhen Haibin Pharmaceutical Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Shenzhen Haibin Pharmaceutical Meropenem Injection Product Portfolio
  30. 8.5.5 Shenzhen Haibin Pharmaceutical Recent Developments
  31. 8.6 Sandoz
  32. 8.6.1 Sandoz Company Information
  33. 8.6.2 Sandoz Business Overview
  34. 8.6.3 Sandoz Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz Meropenem Injection Product Portfolio
  36. 8.6.5 Sandoz Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Meropenem Injection Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Luoxin Pharmaceutical
  44. 8.8.1 Luoxin Pharmaceutical Company Information
  45. 8.8.2 Luoxin Pharmaceutical Business Overview
  46. 8.8.3 Luoxin Pharmaceutical Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Luoxin Pharmaceutical Meropenem Injection Product Portfolio
  48. 8.8.5 Luoxin Pharmaceutical Recent Developments
  49. 8.9 United Laboratories
  50. 8.9.1 United Laboratories Company Information
  51. 8.9.2 United Laboratories Business Overview
  52. 8.9.3 United Laboratories Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 United Laboratories Meropenem Injection Product Portfolio
  54. 8.9.5 United Laboratories Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Meropenem Injection Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Hainan Haiyao Co., Ltd.
  62. 8.11.1 Hainan Haiyao Co., Ltd. Company Information
  63. 8.11.2 Hainan Haiyao Co., Ltd. Business Overview
  64. 8.11.3 Hainan Haiyao Co., Ltd. Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Hainan Haiyao Co., Ltd. Meropenem Injection Product Portfolio
  66. 8.11.5 Hainan Haiyao Co., Ltd. Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Meropenem Injection Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 PKU HealthCare
  74. 8.13.1 PKU HealthCare Company Information
  75. 8.13.2 PKU HealthCare Business Overview
  76. 8.13.3 PKU HealthCare Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 PKU HealthCare Meropenem Injection Product Portfolio
  78. 8.13.5 PKU HealthCare Recent Developments
  79. 8.14 Sumitomo Dainippon Pharma
  80. 8.14.1 Sumitomo Dainippon Pharma Company Information
  81. 8.14.2 Sumitomo Dainippon Pharma Business Overview
  82. 8.14.3 Sumitomo Dainippon Pharma Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sumitomo Dainippon Pharma Meropenem Injection Product Portfolio
  84. 8.14.5 Sumitomo Dainippon Pharma Recent Developments
  85. 8.15 Sagent Pharmaceuticals
  86. 8.15.1 Sagent Pharmaceuticals Company Information
  87. 8.15.2 Sagent Pharmaceuticals Business Overview
  88. 8.15.3 Sagent Pharmaceuticals Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Sagent Pharmaceuticals Meropenem Injection Product Portfolio
  90. 8.15.5 Sagent Pharmaceuticals Recent Developments
  91. 8.16 Macleods Pharmaceuticals
  92. 8.16.1 Macleods Pharmaceuticals Company Information
  93. 8.16.2 Macleods Pharmaceuticals Business Overview
  94. 8.16.3 Macleods Pharmaceuticals Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Macleods Pharmaceuticals Meropenem Injection Product Portfolio
  96. 8.16.5 Macleods Pharmaceuticals Recent Developments
  97. 8.17 Johnlee Pharmaceuticals
  98. 8.17.1 Johnlee Pharmaceuticals Company Information
  99. 8.17.2 Johnlee Pharmaceuticals Business Overview
  100. 8.17.3 Johnlee Pharmaceuticals Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Johnlee Pharmaceuticals Meropenem Injection Product Portfolio
  102. 8.17.5 Johnlee Pharmaceuticals Recent Developments
  103. 8.18 Bionova Scientific
  104. 8.18.1 Bionova Scientific Company Information
  105. 8.18.2 Bionova Scientific Business Overview
  106. 8.18.3 Bionova Scientific Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Bionova Scientific Meropenem Injection Product Portfolio
  108. 8.18.5 Bionova Scientific Recent Developments
  109. 8.19 AuroMedics
  110. 8.19.1 AuroMedics Company Information
  111. 8.19.2 AuroMedics Business Overview
  112. 8.19.3 AuroMedics Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 AuroMedics Meropenem Injection Product Portfolio
  114. 8.19.5 AuroMedics Recent Developments
  115. 8.20 Amneal Pharmaceuticals
  116. 8.20.1 Amneal Pharmaceuticals Company Information
  117. 8.20.2 Amneal Pharmaceuticals Business Overview
  118. 8.20.3 Amneal Pharmaceuticals Meropenem Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Amneal Pharmaceuticals Meropenem Injection Product Portfolio
  120. 8.20.5 Amneal Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Meropenem Injection Value Chain Analysis
  2. 9.1.1 Meropenem Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Meropenem Injection Production Mode & Process
  6. 9.2 Meropenem Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Meropenem Injection Distributors
  9. 9.2.3 Meropenem Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst